Clinical Overview

Ectopic atrial tachycardia (EAT) is a fast heart rhythm driven from a single site in the atria outside the sinus node, producing one consistent non-sinus P-wave morphology at an atrial rate that is highly variable but typically runs 100-250 bpm (Kaplan and Lala, StatPearls, 2023). Cleveland Clinic’s own patient-facing reference for atrial tachycardia lists “ectopic atrial tachycardia” and “focal atrial tachycardia” alongside “atrial tachycardia” as names for the same entity, distinguished only by which feature of the mechanism the name emphasizes — an ectopic origin versus a focal, single-site origin (Cleveland Clinic, reviewed 2025). LITFL similarly treats “focal atrial tachycardia” and plain “atrial tachycardia” as interchangeable terms (Burns and Buttner, LITFL ECG Library, 2024).

This dataset’s own SNOMED CT coding keeps “AT” and “EAT” as two separate labels, and a direct record-level check of the production dataset finds that no single record carries both labels together — the two are applied as mutually exclusive categories, not as overlapping or redundant terms for the same finding. That confirms the labels were assigned as a genuine either/or choice at annotation time, but not what clinical criterion, if any, drove that choice. [CLINICAL REVIEW NEEDED: the source dataset’s own AT-vs-EAT annotation protocol is not publicly documented. Independent record-level review for this page confirms the two labels never co-occur on the same record in this dataset, sharpening but not resolving the open question already flagged on the atrial-tachycardia page — a strip carrying either label should still be read as an atrial tachycardia by ECG criteria, not assumed to differ mechanistically from the other.]

Three mechanisms produce EAT: enhanced automaticity (an ectopic focus depolarizing on its own accelerated schedule, the most common driver and the one that produces the classic gradual “warm-up” and “cool-down”), triggered activity (afterdepolarizations tied to intracellular calcium handling), and micro-reentry (a small self-sustaining circuit, harder to distinguish from an automatic focus on a surface ECG) — a 2022 multicenter cohort of ablated focal ATs found automaticity or triggered activity behind 94% of cases and micro-reentry behind the remaining 6% (Compagnucci et al., Journal of Clinical Medicine, 2022).

EAT is a well-established entity in pediatric electrophysiology practice, and it is also a recognized complication after congenital heart disease surgery: a retrospective review of 5,372 infant cardiac surgeries found postoperative EAT in 129 cases (2.5%), with younger age, lower surgical weight, DiGeorge syndrome, total anomalous pulmonary venous connection repair, and longer or more complex procedures as significant risk factors (Uniat et al., Pediatric Cardiology, 2022). Most focal EAT is benign, but incessant or high-burden episodes carry real downstream risk: prolonged tachycardia can produce tachycardia-induced cardiomyopathy (University of Wisconsin Advanced EKG/EGM Resource, Atrial Ectopic Tachycardia, 2022; Liwanag and Willoughby, StatPearls, 2023).

Symptoms track the ventricular rate and how long the episode lasts: palpitations, dizziness, chest discomfort, and shortness of breath are the most commonly reported complaints in older children and adults, and some episodes are entirely asymptomatic, first identified incidentally on telemetry or a Holter recording (Cleveland Clinic, reviewed 2025; Liwanag and Willoughby, StatPearls, 2023). Infants and young children more often present nonspecifically — poor feeding, fussiness, vomiting, pallor, or rapid breathing rather than reported palpitations (Cleveland Clinic, reviewed 2025).

Recognized triggers and risk factors include congenital heart disease and prior cardiac surgery (Uniat et al., Pediatric Cardiology, 2022), stimulants, alcohol use, digoxin toxicity, electrolyte disturbances, hypoxia, heightened sympathetic tone from acute illness, fever, or stress, and structural or ischemic heart disease — though EAT also occurs in structurally normal hearts (Liwanag and Willoughby, StatPearls, 2023; Cleveland Clinic, reviewed 2025).

Interpretation Guide

Key Features:

• Atrial rate highly variable, typically 100-250 bpm, with the ventricular rate matching it whenever AV conduction is 1:1 (Kaplan and Lala, StatPearls, 2023)
• Ventricular rhythm follows AV conduction: regular at a fixed 1:1 ratio when conduction keeps pace with the atrial rate, or intermittently irregular when AV block — physiologic at very fast atrial rates, or digoxin-induced — drops some atrial beats (Liwanag and Willoughby, StatPearls, 2023)
• P waves: a single, consistent non-sinus morphology, clearly different from the patient’s own sinus P wave, and separated from neighboring P waves by a flat, isoelectric baseline, unlike atrial flutter’s continuous sawtooth pattern (Burns and Buttner, LITFL ECG Library, 2024)
• PR interval: variable; may appear short, or the P wave may sit far enough from the preceding QRS that the RP interval is the more useful measurement, depending on the atrial rate and AV conduction (Liwanag and Willoughby, StatPearls, 2023)
• QRS complex: narrow and normal in morphology unless a pre-existing bundle branch block or rate-related aberrant conduction is present (Burns and Buttner, LITFL ECG Library, 2024)
• ST segment and T waves are not primary diagnostic features of ectopic atrial tachycardia
• QT interval is not a primary diagnostic feature at these rates; treat any measurement as provisional until the rhythm slows or converts
• Other findings: a gradual “warm-up” at onset and “cool-down” at termination, with more beat-to-beat rate variability than a reentrant rhythm such as atrial flutter, is characteristic of the automatic mechanism behind most EAT (University of Wisconsin Advanced EKG/EGM Resource, Atrial Ectopic Tachycardia, 2022). Because the arrhythmia is generally not AV-node-dependent, it is generally not converted by adenosine, though adenosine can occasionally slow or terminate it and may still transiently unmask the underlying atrial activity, unlike its typically rhythm-terminating effect in AV-node-dependent reentrant SVT (University of Wisconsin Advanced EKG/EGM Resource, Atrial Ectopic Tachycardia, 2022; Burns and Buttner, LITFL ECG Library, 2024)

The most useful bedside clue is the pattern of onset and offset rather than the rate itself: a tachycardia that visibly speeds up over its first several beats and slows before stopping points toward an automatic focus, while a rhythm that switches on and off at a fixed rate points toward a reentrant circuit such as AVNRT, AVRT, or atrial flutter. Because electrical cardioversion without concurrent medical therapy will likely be followed by recurrence in an automatic focus that simply restarts itself, mistaking the mechanism at the bedside can lead toward a shock that will not hold (Liwanag and Willoughby, StatPearls, 2023).

Key Leads

• Lead V1 — the single most useful lead for distinguishing a right- from a left-sided focus: a positive P wave in V1 favors a left atrial origin (93% sensitivity, 88% specificity in one prospective algorithm), while a negative or biphasic P wave favors a right atrial origin (Kaplan and Lala, StatPearls, 2023).
• Lead aVL — a secondary confirmatory lead for the same right-versus-left question: a positive or biphasic P wave in aVL favors a right atrial origin (88% sensitivity, 79% specificity) (Kaplan and Lala, StatPearls, 2023).
• A comparison tracing in sinus rhythm — not a lead, but the most useful adjunct: the defining finding is a P wave that looks different from the patient’s own baseline sinus P wave, which is easiest to confirm against a prior strip. This condition is not lead-agnostic — V1 and aVL carry disproportionate weight for localization — but the core recognition (a discrete, non-sinus P wave preceding each QRS, at a rate that often warms up and cools down) can be made from any lead with a clear baseline.

Differential Diagnosis

• Atrial Flutter — also produces a fast, often regular rhythm, but flutter’s atrial waves run together in a continuous sawtooth pattern with no isoelectric baseline between them, versus EAT’s discrete P waves separated by a flat baseline, typically at a slower atrial rate than flutter’s.
• Supraventricular Tachycardia (SVT) — the broader umbrella that EAT sits inside; the AV-node-dependent forms most often labeled “SVT” at the bedside (AVNRT, AVRT) are reentrant and start and stop abruptly, while EAT is typically automatic and shows a gradual warm-up and cool-down.
• Sinus Tachycardia — the P wave keeps the patient’s normal sinus morphology (upright in I, II, and aVF) and the rate drifts gradually with activity, fever, pain, or volume status, whereas EAT’s P wave is a distinct, non-sinus morphology that stays constant once the tachycardia is established.
• Atrial Fibrillation — no organized, repeating P wave at all, with an irregularly irregular ventricular response, versus EAT’s single consistent P-wave morphology and a ventricular response that is typically regular or predictably blocked.

Treatment Brief

Confirm lead placement and capture a longer strip whenever a new fast, narrow-complex rhythm appears, and note whether the rate visibly warms up and cools down at onset and offset — that detail helps the receiving provider distinguish an automatic focus from a reentrant SVT before any intervention is chosen. Correlate the rhythm with vital signs and symptoms, and notify the provider for a new or hemodynamically significant finding, especially in an infant or young child presenting nonspecifically (poor feeding, fussiness, rapid breathing) rather than with reported palpitations.

Because most EAT is driven by an ectopic focus firing on its own schedule rather than a reentrant circuit, standalone electrical cardioversion tends not to hold — “electrical cardioversion without concurrent medical therapy will likely result in arrhythmia recurrence” (Liwanag and Willoughby, StatPearls, 2023). First-line management instead targets the underlying trigger — treating the acute illness or fever, stopping stimulants, correcting a digoxin level, or addressing an electrolyte imbalance — alongside ventricular rate control with beta-blockers or non-dihydropyridine calcium channel blockers (Liwanag and Willoughby, StatPearls, 2023; Cleveland Clinic, reviewed 2025). Overdrive pacing can transiently suppress the focus, though the tachycardia typically resumes once pacing stops (University of Wisconsin Advanced EKG/EGM Resource, Atrial Ectopic Tachycardia, 2022). Persistent or recurrent episodes may need an antiarrhythmic, and catheter ablation is the guideline-recommended definitive therapy for recurrent or incessant EAT: a multicenter cohort reported catheter ablation acutely effective in every treated case, with recurrence in 20% of patients over a median follow-up of roughly nine months (288 days) (Compagnucci et al., Journal of Clinical Medicine, 2022) — Cleveland Clinic describes the cure rate for focal atrial tachycardia today as “very high” (Cleveland Clinic, reviewed 2025). Adenosine can help sort out the mechanism at the bedside — EAT is generally not converted by adenosine, though it can occasionally slow or terminate the rhythm, unlike its typical termination of AV-node-dependent reentrant SVT (University of Wisconsin Advanced EKG/EGM Resource, Atrial Ectopic Tachycardia, 2022) — but does not substitute for capturing a clean strip for later review.